FTC Study projects significant cost savings to consumers from banning "pay-for-delay" drug settlements | Practical Law

FTC Study projects significant cost savings to consumers from banning "pay-for-delay" drug settlements | Practical Law

In a speech at the Centre for American Progress on 23 June 2009, US Federal Trade Commission (FTC) Chairman Jon Leibowitz said that eliminating so-called "pay-for-delay" pharmaceutical settlements will save US consumers US$3.5 billion dollars each year, according to an internal study.

FTC Study projects significant cost savings to consumers from banning "pay-for-delay" drug settlements

by Practical Law
Law stated as at 23 Jun 2009 • USA (National/Federal)
In a speech at the Centre for American Progress on 23 June 2009, US Federal Trade Commission (FTC) Chairman Jon Leibowitz said that eliminating so-called "pay-for-delay" pharmaceutical settlements will save US consumers US$3.5 billion dollars each year, according to an internal study.